October 5, 2018

Should You Take Aspirin to Lower Your Liver Cancer Risk?

The Latest from Health Central. Forward to a friend | View Online
 
t.png p.png
8975842d-d31a-4ad4-95a9-bcce47223048.jpg
Aspirin Lowers Liver Cancer Risk, Study Confirms
JAMA Oncology — An analysis of two long-term studies suggests taking two or more 325 mg aspirin tablets a week for at least five years significantly reduces the risk of primary liver cancer (hepatocellular carcinoma), the second leading cause of cancer-related deaths worldwide.
Read More »
Could This Weight Loss Drug Help Prevent Type 2 Diabetes?
The Lancet — Lorcaserin (Belviq), a drug approved to promote weight loss in people with obesity, can decrease the risk for type 2 diabetes and diabetes-related complications.
Read More »
Maybe You Can Keep Your Pet Even if You Have Asthma
CHEST — Once asthma treatment guidelines are implemented, environmental exposure to pets or secondhand smoke is not a significant factor in asthma control over time, according to researchers.
Read More »
Should Colon Cancer Screening Begin at 45?
Berkeley Wellness — Guidelines from most health agencies, including the CDC, recommend colorectal cancer screening from ages 50 to 75, but the American Cancer Society recently lowered its recommendation to 45.
Read More »
3 Caffeine-Free Teas for Acid Reflux Relief
HealthCentral — If you're living with acid reflux and find caffeine worsens your symptoms, you may avoid beverages like coffee and tea. Here are three to try — and they may even provide relief.
Read More »
imp?s=187247&sz=300x250&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=176666ad45
imp?s=187248&sz=1x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=176666ad45 imp?s=187249&sz=1x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=176666ad45
imp?s=95371&sz=116x15&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=176666ad45 imp?s=96074&sz=69x15&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=176666ad45
What you missed this week
More from Heath Central
The Remedy Health Network
Berkeley Wellness science-backed, expert-vetted health and wellness advice

The Body current and complete coverage for the HIV/AIDS community
Newsletter Options
This email was sent to clrmyers6@gmail.com

We're happy to help you unsubscribe or manage your email preferences.

If this email was forwarded to you by another email recipient and you would like to subscribe, click here.

Ensure you receive this newsletter by adding us to your safe sender's list.

You can also forward this newsletter to a friend.
t.png p.png
imp?s=124359000&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=176666ad45 imp?s=124359001&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=176666ad45 imp?s=124359002&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=176666ad45 imp?s=124359003&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=176666ad45 imp?s=124359004&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=176666ad45 imp?s=124359005&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=176666ad45 imp?s=124359006&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=176666ad45 imp?s=124359007&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=176666ad45 imp?s=124359008&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=176666ad45 imp?s=124359009&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=176666ad45 imp?s=124359010&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=176666ad45 imp?s=124359011&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=176666ad45 imp?s=124359012&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=176666ad45 imp?s=124359013&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=176666ad45 imp?s=124359014&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=176666ad45 imp?s=124359015&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=176666ad45 imp?s=124359016&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=176666ad45 imp?s=124359017&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=176666ad45 imp?s=124359018&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=176666ad45 imp?s=124359019&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=176666ad45

No comments:

Post a Comment